Clinical Trials
149 trialsEfficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC
Innovent Biologics (Suzhou) Co. Ltd.
ENSPIRIT
Achieve Life Sciences
Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)
Merck Sharp & Dohme LLC
Bintrafusp Alfa Program Rollover Study
EMD Serono
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
VITAL
Sanofi
Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer
University Hospital, Limoges
PROStep
Abramson Cancer Center at Penn Medicine
Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer
Wake Forest University Health Sciences
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
Novartis
LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer
Novartis
ZEAL
Sanofi
A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
Samsung Bioepis Co., Ltd.
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Radiation Therapy Oncology Group
POISE
The Canadian College of Naturopathic Medicine
Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients
Menoufia University
CheckMate870
Bristol-Myers Squibb
TRIIL
RDO Pharm.
MERMAID-2
AstraZeneca
ADELOS
AstraZeneca
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
Swiss Cancer Institute
Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Canadian Cancer Trials Group
PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer
Canadian Cancer Trials Group
CheckMate331
Bristol-Myers Squibb
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
Eastern Cooperative Oncology Group
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed
Eastern Cooperative Oncology Group
EQUAL
Georgetown University
Elucidate
On Target Laboratories, LLC
Ultimate
Intergroupe Francophone de Cancerologie Thoracique
MODEL
Intergroupe Francophone de Cancerologie Thoracique
CheckMate 384
Bristol-Myers Squibb
BEMP
Southern Illinois University
CheckMate 451
Bristol-Myers Squibb
Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer
Ionis Pharmaceuticals, Inc.
Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT
HTA Co., Ltd.
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Alliance for Clinical Trials in Oncology
CLNS
St. Joseph's Healthcare Hamilton
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Radiation Therapy Oncology Group
Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer
Sumitomo Pharma Co., Ltd.
HA-PCI
The Netherlands Cancer Institute
ASTRIS
AstraZeneca
Study of Participants With Advanced Non-Small Cell Lung Cancer
Eli Lilly and Company
Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers
University of Wisconsin, Madison
Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Wake Forest University Health Sciences
ALTA-1L
Takeda
AMPLCaRe
The Canadian College of Naturopathic Medicine
Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
UNICANCER
A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer
Genentech, Inc.